Three things drift apart in celiac and get confused: how you feel, what your antibodies say, what your gut looks like. Symptoms clear first, antibodies fall next, the villi heal last, in many adults never fully 1. So a normal antibody doesn't confirm a healed gut; the test is only about 50% sensitive for ongoing damage 2.
The gap is not academic. Villi that don't heal run a lymphoma rate near 102 per 100,000 a year against 32 per 100,000 in those that do 3. The same silent damage drives the deficiencies you feel: four in five adults have a nutrient low at diagnosis, zinc short in roughly 59% 4 5. The bone loss is there too: a third osteoporotic at diagnosis, hip-fracture risk up about 70% 6 7.
Book the dietitian first. It's the highest-yield year-one move, and most guidelines make it mandatory 8. Then the labs:
The two-year biopsy is the contested piece. A repeat endoscopy is the only direct way to confirm healing, but there's no mortality gap between healed and not-healed groups 11, so consider it after shared decision-making at two years 8. If antibodies stay up or symptoms linger, it's not optional.
Your family is the part that gets dropped. Each first-degree relative carries roughly a one-in-ten chance of the disease, sevenfold over the general population 10. Most feel fine, having blamed the fatigue or brain fog on age. Across three or four relatives, the odds say one tests positive, and finding them early is most of the lasting value.
The arc, if you stay on it.
- Six months: antibodies falling, hidden gluten caught, fatigue lifting once iron and B12 are replaced.
- Year one: a clean bone baseline, or osteopenia flagged early enough to treat before a fracture.
- Year two: healed histology puts lymphoma risk near baseline 3. The compound win is the relative diagnosed at 38 instead of 53.
The fine print — when to skip it, and what people get wrong
Where it falls apart. Dropping out after year one, so the family never gets tested. Trusting a normal antibody, which misses half of ongoing damage 2. A relative going gluten-free before testing erases the findings 9.
A point that leaks into primary care: the USPSTF declined to endorse screening asymptomatic adults 12. That's the general population, at one in a hundred; your relatives sit at one in ten, and every society recommends testing them 8.
- 1Rubio-Tapia A, Rahim MW, See JA, Lahr BD, Wu TT, Murray JA (2010). Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. American Journal of Gastroenterology. link
- 2Husby S, Murray JA, Katzka DA (2019). AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease — Changing Utility of Serology and Histologic Measures: Expert Review. Gastroenterology. link
- 3Lebwohl B, Granath F, Ekbom A, Smedby KE, Murray JA, Neugut AI, Green PHR, Ludvigsson JF (2013). Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Annals of Internal Medicine. link
- 4Bledsoe AC, King KS, Larson JJ, Snyder M, Absah I, Choung RS, Murray JA (2019). Micronutrient Deficiencies Are Common in Contemporary Celiac Disease Despite Lack of Overt Malabsorption Symptoms. Mayo Clinic Proceedings. link
- 5Wierdsma NJ, van Bokhorst-de van der Schueren MAE, Berkenpas M, Mulder CJJ, van Bodegraven AA (2013). Vitamin and Mineral Deficiencies Are Highly Prevalent in Newly Diagnosed Celiac Disease Patients. Nutrients. link
- 6Heikkilä K, Pearce J, Mäki M, Kaukinen K (2015). Celiac disease and bone fractures: a systematic review and meta-analysis. Journal of Clinical Endocrinology & Metabolism. link
- 7Olmos M, Antelo M, Vazquez H, Smecuol E, Mauriño E, Bai JC (2008). Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Digestive and Liver Disease. link
- 8Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, Lebwohl B (2023). American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. American Journal of Gastroenterology. link
- 9Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, Green PHR, Hadjivassiliou M, Holdoway A, van Heel DA, Kaukinen K, Leffler DA, Leonard JN, Lundin KEA, McGough N, Davidson M, Murray JA, Swift GL, Walker MM, Zingone F, Sanders DS (2014). Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. link
- 10Singh P, Arora S, Lal S, Strand TA, Makharia GK (2015). Risk of Celiac Disease in the First- and Second-Degree Relatives of Patients With Celiac Disease: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. link
- 11Lebwohl B, Granath F, Ekbom A, Montgomery SM, Murray JA, Rubio-Tapia A, Green PHR, Ludvigsson JF (2013). Mucosal healing and mortality in coeliac disease. Alimentary Pharmacology & Therapeutics. link
- 12USPSTF (2017). Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement. JAMA. link
დაკავშირებული სახელმძღვანელოში (6)
- — Celiac clusters with other autoimmune conditions, often quietly. If one is diagnosed, the rest are worth screening for.
- — A damaged gut leaves nutrient gaps — iron is the classic one, which is why follow-up labs check ferritin.
- — Rule out celiac first, while you're still eating gluten — going gluten-free before testing hides the disease this is the step to exclude.
- — Celiac quietly thins bone before diagnosis — the bone-density scan is part of follow-up for a reason.
- — Celiac travels with type 1 diabetes — same autoimmune genes. If T1D runs in the family too, ask about screening relatives.
- — A damaged gut absorbs fat-soluble vitamins poorly, so low vitamin D is common, and it feeds the bone loss the scan checks for.
Celiac Follow-Up and Family Screening
In insured settings, annual tTG and nutrient panel plus baseline DXA are typically covered; out-of-pocket is well under $500/year for most patients. Uninsured costs (DXA ~$100-200, comprehensive panel ~$200-400) sit in the trivial-to-minor range.
Mucosal healing surveillance stratifies lymphoma risk substantially: persistent villous atrophy carries 3.3x the lymphoma incidence of healed mucosa (102 vs 31 per 100,000/yr) and ~2.81x the population rate (Lebwohl 2013, Ann Intern Med). FDR case-finding identifies the 7.5% of relatives carrying undiagnosed disease (Singh 2015). All-cause mortality finding from same cohort is null (Lebwohl 2013, Aliment Pharmacol Ther) — strong on disease-specific endpoints, more equivocal on lifespan.
A handful of yearly lab draws, one or two gastroenterology visits, dietitian visits in the first year, and prompting family members to screen — minor compared to the daily GFD effort itself, but more than zero.
Multiple major society guidelines (ACG 2023, BSG 2014, AGA 2019) converge on the core protocol. The Lebwohl 2013 Swedish cohort (n=7,648) and the Rubio-Tapia 2010 Mayo cohort anchor the mucosal-healing claims. Singh 2015 meta-analysis settles FDR prevalence. Some elements (follow-up biopsy cadence, DXA timing) are contested between guidelines — not a 5.
Detecting and correcting iron/B12/folate/vit-D/zinc deficiencies (87% have at least one deficiency at diagnosis per Wierdsma 2013; 59% zinc-deficient per Bledsoe 2019), plus dietitian-driven adherence in the first year, delivers clear functional improvements — less anemia-driven fatigue, fewer headaches, fewer cross-contamination flares.
Iron-deficiency anemia is present in ~32% of newly-diagnosed celiacs (Wierdsma 2013); B12 and folate deficiencies common; identifying and replacing these via the annual nutrient panel removes a real fatigue floor that GFD alone often doesn't lift fast enough.
B12 and iron correction improve cognitive symptoms; the felt 'brain fog' that many celiac patients report tracks with these deficiencies. Modest because the focus lift is downstream of nutrient correction rather than a direct mechanism.
B12/folate/iron correction lifts depressive symptoms in deficient patients; reduced uncertainty about disease status (mucosal healed, family screened) lowers chronic-illness anxiety. Real but secondary.
Correcting iron, zinc, and vitamin D deficiencies caught on follow-up labs has secondary effects on hair, nail, and skin quality over months; zinc deficient in 59% of newly diagnosed patients (Bledsoe 2019). Modest and indirect, but real.